Prostate Cancer
Conference Coverage
Prostate cancer subgroup may benefit from intensified therapy
A new trial explored whether for patients with prostate cancer who have unfavorable features and a detectable PSA following a radical...
Conference Coverage
Talazoparib add-on improves outcomes in metastatic prostate cancer
As determined on the basis of imaging, PFS was 37% better for talazoparib plus enzalutamide than for enzalutamide monotherapy.
Conference Coverage
Rucaparib benefit in BRCA+ prostate cancer confirmed
New study finding provides evidence of clinical benefit for an indication for rucaparib that was granted an accelerated approval in May 2020.
Conference Coverage
Colorectal cancer treatment outcomes in older adults
Disease-free survival boosted by adjuvant therapy completion, but only about half of patients finish.
News
New cancer data spark outcry from patient advocates
The American Cancer Society on Jan. 13 revealed what it called ‘alarming’ news about prostate cancer.
News
‘Low-value’ prostate cancer screening prevalent in primary care
A new study shows that testing for prostate-specific antigen and also digital rectal examinations are both carried out frequently in older men.
Clinical Topics & News
Improving Bone Health in Patients With Advanced Prostate Cancer With the Use of Algorithm-Based Clinical Practice Tool at Salt Lake City VA
Clinical Topics & News
Palliative Care Disparities in Small Cell Carcinoma of the Prostate: An Analysis of the National Cancer Database
Article
Utilization and Clinical Benefit of Immune Checkpoint Inhibitor in Veterans With Microsatellite Instability-High Prostate Cancer
Article
Impact of Race on Outcomes of High-Risk Patients With Prostate Cancer Treated With Moderately Hypofractionated Radiotherapy in an Equal Access Setting
Individuals with high-risk prostate cancer treated with MHRT demonstrated favorable clinical outcomes that did not differ by race, alongside...
